stroke
Conditions
Interventions
Experimental groupA:tDCS+FES
Experimental groupB:anode tDCS+FES
Experimental groupC:cathode tDCS+FES
Control group:sham tDCS+FES
Sponsors
Guangdong 999 Brain Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. It conforms to the diagnostic essentials of various major cerebrovascular diseases in China in 2019 by the Neurology Branch of the Chinese Medical Association, and is diagnosed by CT or MRI; 2. First onset, unilateral limb hemiplegia, the course of the disease is 1-3 months; 3. Seat balance is greater than or equal to level 1, without independent walking ability (FAC=7 points); 6. No serious heart, lung, kidney and other related diseases; 7. The patient gave informed consent to this study and signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Progressive stroke; 2. The responsible lesion is located in the brain stem or cerebellum; 3. Those who have skin damage or infection on the head or lower limbs of the affected side that affect the application of electrodes; 4. Muscle tension of the ankle plantar flexor group MAS>=3; 5. Patients with craniocerebral trauma or malignant tumor; 6. Other neuromuscular and bone and joint diseases that affect physical activity; 7. Those with skull defects, metal implants in the brain, and pacemakers;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugl-Meyer assessment;Surface electromyography;Motor evoked potential; | — |
Secondary
| Measure | Time frame |
|---|---|
| Modified Ashworth Scale;Berg Balance Scale;Modified Barthel Index; | — |
Countries
China
Contacts
Public ContactChen Hanbo
Guangdong 999 Brain Hospital
Outcome results
None listed